Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Not applicableUnknownNCT01703637
What this trial is testing

Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin

Who this might be right for
Type 2 Diabetes Mellitus
Lin Liao 300
Large-scale testing (Phase 3)Study completedNCT01197157
What this trial is testing

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

Who this might be right for
Hepatitis C
National Liver Institute, Egypt 200
Not applicableStudy completedNCT01204905
What this trial is testing

R5 Integrase Study in HIV-1 Naive Patients

Who this might be right for
HIV Infections
University of Maryland, Baltimore 7
Large-scale testing (Phase 3)WithdrawnNCT01563601
What this trial is testing

Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Cephalon
Not applicableStudy completedNCT00212940
What this trial is testing

Supportive Therapy for Adherence to ART(STAART)

Who this might be right for
HIV Infections
Ottawa Hospital Research Institute 112
Testing effectiveness (Phase 2)Study completedNCT04265261
What this trial is testing

Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Hoffmann-La Roche 139
Large-scale testing (Phase 3)Looking for participantsNCT07226089
What this trial is testing

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

Who this might be right for
ISSSGA
Rabin Medical Center 254
Large-scale testing (Phase 3)Study completedNCT00094458
What this trial is testing

Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC

Who this might be right for
Crohn Disease
Centocor Ortho Biotech Services, L.L.C. 508
Testing effectiveness (Phase 2)Study completedNCT03946748
What this trial is testing

Study to Evaluate the Efficacy and Safety of REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Regeneron Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT01363011
What this trial is testing

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 106
Early research (Phase 1)WithdrawnNCT01525212
What this trial is testing

Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Active Not RecruitingNCT05180799
What this trial is testing

BA3071 in Patients With Solid Tumors

Who this might be right for
NSCLCMelanoma
BioAtla, Inc. 320
Post-approval studies (Phase 4)Ended earlyNCT00679926
What this trial is testing

Kaletra and Viread in Antiretroviral Naïve Patients

Who this might be right for
HIV Infections
Oklahoma State University Center for Health Sciences 6
Post-approval studies (Phase 4)Study completedNCT05606055
What this trial is testing

The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection

Who this might be right for
HIV-1-infection
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 100
Testing effectiveness (Phase 2)Ended earlyNCT01166126
What this trial is testing

Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV

Who this might be right for
Mucosal MelanomaRecurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00406302
What this trial is testing

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-small-cell Lung
Wolfgang Hilbe 41
Testing effectiveness (Phase 2)Study completedNCT02217566
What this trial is testing

Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 46
Testing effectiveness (Phase 2)Study completedNCT01666314
What this trial is testing

Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 137
Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Next Page